CEO Today Europe Awards

www.ceotodaymagazine.com 76 CEO Today Europe Awards 2018 the united kingdom EMMA WALMSLEY CEO of GLAXOSMITHKLINE PLC FIRM PROFILE GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world’s sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi. Emma Walmsley became CEO on 31 March 2017 and is the first female CEO of the company. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange. GSK’s drugs and vaccines earned £21.3 billion in 2013. Its top-selling products that year were Advair, Avodart, Flovent, Augmentin, Lovaza and Lamictal. GSK’s consumer products, which earned £5.2 billion in 2013, include Sensodyne and Aquafresh toothpaste, the malted-milk drink Horlicks, Abreva for cold sores, Breathe Right nasal strips, Nico- derm and Nicorette nicotine replacements, and Night Nurse, a cold remedy. The company developed the first malaria vaccine, RTS,S, which it said in 2014 it would make available for five percent above cost. Legacy products developed at GSK include several listed in the World Health Organization Model List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine and zidovudine. ABOUT EMMA WALMSLEY Emma Walmsley has been GSK CEO since April 2017. She is also a member of the GSK Board. Prior to this, Emma was the CEO of GSK Consumer Healthcare, a Joint Venture between GSK and Novartis, from its creation in March 2015, and has been a member of GSK’s Corporate Executive Team since 2011. She joined GSK in 2010, with responsibility for Consumer Healthcare, Europe. Prior to joining GSK, Emma worked with L’Oreal for 17 years where she held a variety of marketing and general management roles in Paris, London and New York. From 2007 she was based in Shanghai as General Manager, Consumer Products for L’Oreal China. Emma was a Non-Executive Director of Diageo plc from 1 January – 21 September 2016. Emma holds an MA in Classics and Modern Languages from Oxford University. Ms. Walmsley served as the leader of Consumer Products business of L’Oreal in China. Previously, she was based in New York where she had global responsibility for the mass-market Maybelline cosmetics business. She has been a Director of GlaxoSmithKline Plc since January 1, 2017. She served as a Non-Executive Director at Diageo plc from January 1, 2016 to September 21, 2016. Ms. Walmsley holds an MA in Classics and Modern Languages from Oxford University. www.gsk.com/Healthcare